Simultaneous Treatment of Alcohol Use and Psychiatric Disorders

Back to all technologies
Download as PDF
2017-VANR-67884
Alcohol use disorder is a chronic relapsing condition that includes alcohol withdrawal syndrome and is frequently comorbid with chronic pain disorders and mood disorders such as depression and anxiety. There are only a few drugs approved to treat alcohol use disorder. Their only goal is to reduce alcohol cravings. They do not treat psychiatric disorders.

Researchers at Purdue University have developed a new technology for treating alcohol use disorder. In addition to targeting reduced alcohol intake, it simultaneously treats depression. This new treatment is meant to help patients suffering from both alcohol use and psychiatric disorders. This treatment should exhibit much fewer side effects and improved efficacy when compared to currently available treatments.

Advantages:
-Simultaneously treats alcohol use and psychiatric disorders
-Exhibits fewer side effects
-Improved efficacy

Potential Applications:
-Patients suffering from both alcohol use and psychiatric disorders
-Alcohol treatment centers
-Hospitals
Dec 10, 2019
NATL-Patent
United States
10/954,224
Mar 23, 2021

Feb 2, 2021
CON-Patent
United States
(None)
(None)

Jun 8, 2018
PCT-Patent
WO
(None)
(None)

Jun 13, 2017
Provisional-Patent
United States
(None)
(None)

Jun 13, 2017
Provisional-Patent
United States
(None)
(None)
Purdue Office of Technology Commercialization
The Convergence Center
101 Foundry Drive, Suite 2500
West Lafayette, IN 47906

Phone: (765) 588-3475
Fax: (765) 463-3486
Email: otcip@prf.org